Norgine is pleased to announce that the Australian Therapeutic Goods Administration (TGA) has approved the registration of IFINWIL® (eflornithine) for the treatment of adults and paediatric patients ...

China approved 48 first-in-class innovative drugs, as well as a significant number of medications for pediatric ... approval of new and effective drugs, so as to provide patients with a broader ...

ONCOTELIC THERAPEUTICS, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS ...

offering hope that a new targeted therapy may become available for patients — both adults and children — living with acquired hypothalamic obesity,” Dr. Susan Phillips, a pediatric ...

We accept various forms of payments: Cash, Check, Visa, Mastercard, Debit card and Care Credit. We accept Ohio Medicaid and Ohio Medicaid Managed Care Plans. To ensure your health and safety, ...

Decoy Therapeutics, Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide conjugate therapeutics, announces that Massachusetts Institute of ...

A new guideline to promote ... medical needs such as the treatment of pediatric and chronic illnesses. Yang Ting, head of the Department of Drug Registration at the National Medical Products ...

Pfizer Inc. announced today that its shareholders and the general public are invited to access its virtual 2025 Annual Meeting of Shareholders at 9:00 a.m. EDT on Thursday, April 24, 2025. Pfizer has ...

March 31, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella or “the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing novel ...

Objective To determine the effects of coenzyme Q10 (CoQ10) for reduction in the severity, frequency of migraine attacks and duration of headache in adult patients with migraine ... PROSPERO ...

Atrium Health Levine Children’s Hospital has launched a new program that would allow its patients to receive treatment at ...